Skip to main content

Table 2 Patient characteristics

From: Effects of localisation of uterine adenomyosis on outcome of in vitro fertilisation/intracytoplasmic sperm injection fresh and frozen-thawed embryo transfer cycles: a multicentre retrospective cohort study

  Advanced group (n = 40) Extrinsic group (n = 9) Intrinsic group (n = 3) P-value
Age (years) 36 (26–41) 37 (30–39) 35 (31–36) 0.403
Body mass index (kg/m 2 ) 23 (18.1–32.5) 19.9 (18.1–23.3) 23.5 (19.5–25.8) 0.018
Duration of infertility (months) 41.5 (6–151) 42 (0–66) 45 (31–90) 0.519
Cause of infertility, n (%)     0.092
Endometriosis 24 (60) 4 (44.4) 0  
Tubal 2 (5) 1 (11.1) 0  
Anovulation 0 0 1 (33.3)  
Mixed 9 (22.5) 3 (33.3) 1 (33.3)  
Unexplained 5 (12.5) 1 (11.1) 1 (33.3)  
Gravidity, n (%) 17/40 (42.5) 4/9 (44.4) 2/3 (66.7) 0.879
Parity, n (%) 7/40 (0–1) 3/9 (0–1) 0 0.411
Miscarriage, n (%) 13/40 (32.5) 1/9 (11.1) 2/3 (66.7) 0.199
Prior IVF/ICSI-ET treatment cycle 0 (0–9) 0 (0–8) 0 (0–6) 0.933
Prior uterine surgery, n (%) 6/40 (15) 2/9 (22.2) 0 0.777
Prior surgery for endometrioma, n (%) 13/40 (32.5) 7/9 (77.8) 1/3 (33.3) 0.035
Presence of endometrioma, n (%) 28/40 (70) 9/9 (100) 0 0.004
Hypermenorrhoea, n (%) 28/40 (70) 5/9 (55.5) 1/3 (33.3) 0.324
Dysmenorrhoea, n (%) 35/40 (87.5) 7/9 (77.8) 2/3 (66.7) 0.354
  1. IVF/ICSI-ET in vitro fertilisation/intracytoplasmic sperm injection-embryo transfer